{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:11:31Z","timestamp":1771470691713,"version":"3.50.1"},"reference-count":21,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Intensified preoperative chemotherapy after (chemo)radiotherapy, (Total Neoadjuvant Therapy\u2013TNT), increases pathological complete response (pCR) rates and local control. In cases of clinically complete response (cCR) and close follow-up, non-operative management (NOM) is feasible. We report early outcomes and toxicities of a long-term TNT regime in a single-center cohort. Fifteen consecutive patients with distal or middle-third locally advanced rectal cancer (UICC stage II\u2013III) were investigated, who received neoadjuvant chemoradiotherapy (total adsorbed dose: 50.4 Gy in 28 fractions and two concomitant courses 5-fluorouracil (250 mg\/m2\/d)\/oxaliplatin (50 mg\/m2), followed by consolidating chemotherapy (nine courses of FOLFOX4). NOM was offered if staging revealed cCR 2 months after TNT, with resection performed otherwise. The primary endpoint was complete response (pCR + cCR). Treatment-related side effects were quantified for up two years after TNT. Ten patients achieved cCR, of whom five opted for NOM. Ten patients (five cCR and five non-cCR) underwent surgery, with pCR confirmed in the five patients with cCR. The main toxicities comprised leukocytopenia (13\/15), fatigue (12\/15) and polyneuropathy (11\/15). The most relevant CTC \u00b0III + IV events were leukocytopenia (4\/15), neutropenia (2\/15) and diarrhea (1\/15). The long-term TNT regime resulted in promising response rates that are higher than the response rates of short TNT regimes. Overall tolerability and toxicity were comparable with the results of prospective trials.<\/jats:p>","DOI":"10.3390\/curroncol30060407","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T04:21:27Z","timestamp":1685593287000},"page":"5366-5378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-Term Total Neoadjuvant Therapy Leads to Impressive Response Rates in Rectal Cancer: Results of a German Single-Center Cohort"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8751-9862","authenticated-orcid":false,"given":"Georg W.","family":"Wurschi","sequence":"first","affiliation":[{"name":"Clinician Scientist Program, Interdisciplinary Center for Clinical Research (IZKF), Department of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4172-6321","authenticated-orcid":false,"given":"Stefan","family":"Knippen","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2147-489X","authenticated-orcid":false,"given":"Thomas","family":"Ernst","sequence":"additional","affiliation":[{"name":"University Tumor Center (UTC), Jena University Hospital, 07747 Jena, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3565-0699","authenticated-orcid":false,"given":"Claus","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Vascular Surgery, Jena University Hospital, 07747 Jena, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herry","family":"Helfritzsch","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Thoracic Surgery, Thuringia-Clinic Saalfeld Georgius Agricola, 07318 Saalfeld, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Mothes","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Vascular Surgery, Sophien-und Hufeland-Klinikum Weimar, 99425 Weimar, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Liebe","sequence":"additional","affiliation":[{"name":"Department of General and Visceral Surgery, SRH Wald-Klinikum Gera, 07548 Gera, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Huber","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Vascular Surgery, Robert-Koch-Hospital, 99510 Apolda, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Wittig","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_2","first-page":"8","article-title":"Totale Neoadjuvante Therapie als Organerhaltende Therapie des Rektumkarzinoms: Die CAO\/ARO\/AIO-16 Phase II Studie","volume":"198","author":"Gani","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): A multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy","volume":"40","author":"Patil","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000499167","article-title":"Watchful Waiting after Radiochemotherapy in Rectal Cancer: When Is It Feasible?","volume":"35","author":"Gani","year":"2019","journal-title":"Visc. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e215445","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO\/ARO\/AIO-12 Randomized Clinical Trial","volume":"8","author":"Fokas","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/DCR.0000000000000862","article-title":"Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection\u2014A Matched-Controlled Study","volume":"60","author":"Hupkens","year":"2017","journal-title":"Dis. Colon Rectum"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): Final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"Graeven","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/annonc\/mdy205","article-title":"Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: A post hoc analysis of the CAO\/ARO\/AIO-04 phase III trial","volume":"29","author":"Hofheinz","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1200\/JCO.19.00016","article-title":"Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial","volume":"37","author":"Hong","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_12","first-page":"Cd004078","article-title":"Postoperative adjuvant chemotherapy in rectal cancer operated for cure","volume":"2012","author":"Petersen","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: Long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10008","DOI":"10.1038\/s41598-019-46457-5","article-title":"Adjuvant chemotherapy in rectal cancer patients who achieved a pathological complete response after preoperative chemoradiotherapy: A systematic review and meta-analysis","volume":"9","author":"Lim","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_15","unstructured":"ACO, AIO, and ARO (2023, February 20). Konsentierte Stellungnahme der AIO, der ACO und der ARO zur Neoadjuvanten Therapie Beim Rektumkarzinom. Available online: www.aio-portal.de."},{"key":"ref_16","unstructured":"ACO, AIO, and ARO (2023, February 20). Konsentierte Stellungnahme der ACO, der AIO und der ARO zum \u201eWatch and Wait\u201c-Konzept Mit intendiertem Organerhalt bei Rektumkarzinomen des mittleren und unteren Drittels. Available online: https:\/\/www.aio-portal.de\/stellungnahmen.html."},{"key":"ref_17","first-page":"249","article-title":"Management of oxaliplatin-induced peripheral neuropathy","volume":"1","author":"Saif","year":"2005","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"Figer","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_19","first-page":"88","article-title":"Adjuvant chemotherapy in locally advanced rectal cancer: Deciding on the optimal strategy","volume":"72","year":"2020","journal-title":"Rev. Investig. Clin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e33575","DOI":"10.1097\/MD.0000000000033575","article-title":"Planning adaptive treatment by longitudinal response assessment implementing MR imaging, liquid biopsy and analysis of microenvironment during neoadjuvant treatment of rectal cancer (PRIMO)","volume":"102","author":"Wurschi","year":"2023","journal-title":"Medicine"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/6\/407\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:46:15Z","timestamp":1760125575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/6\/407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["curroncol30060407"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30060407","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}